159 related articles for article (PubMed ID: 27540279)
1. NAD(P)H:quinone oxidoreductase 1 inducer activity of some novel anilinoquinazoline derivatives.
Ghorab MM; Alsaid MS; Higgins M; Dinkova-Kostova AT; Shahat AA; Elghazawy NH; Arafa RK
Drug Des Devel Ther; 2016; 10():2515-24. PubMed ID: 27540279
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, molecular modeling and NAD(P)H:quinone oxidoreductase 1 inducer activity of novel 2-phenylquinazolin-4-amine derivatives.
Ghorab MM; Alsaid MS; Higgins M; Dinkova-Kostova AT; Shahat AA; Elghazawy NH; Arafa RK
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1612-8. PubMed ID: 27052554
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, molecular modeling and NAD(P)H:quinone oxidoreductase 1 inducer activity of novel cyanoenone and enone benzenesulfonamides.
Ghorab MM; Higgins M; Alsaid MS; Arafa RK; Shahat AA; Dinkova-Kostova AT
J Enzyme Inhib Med Chem; 2014 Dec; 29(6):840-5. PubMed ID: 24417210
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel 2-phenylquinazoline-4-amine derivatives: identification of 6-phenyl-8H-benzo[g]quinazolino[4,3-b]quinazolin-8-one as a highly potent inducer of NAD(P)H quinone oxidoreductase 1.
Ghorab MM; Alsaid MS; El-Gazzar MG; Higgins M; Dinkova-Kostova AT; Shahat AA
J Enzyme Inhib Med Chem; 2016; 31(sup1):34-39. PubMed ID: 27033734
[TBL] [Abstract][Full Text] [Related]
5.
Vaghefinezhad N; Farsani SF; Gharaghani S
Curr Drug Discov Technol; 2021; 18(1):139-157. PubMed ID: 31721705
[TBL] [Abstract][Full Text] [Related]
6. NAD(P)H:quinone oxidoreductase 1 activity reduces hypertrophy in 3T3-L1 adipocytes.
Vomhof-DeKrey EE; Picklo MJ
Free Radic Biol Med; 2012 Aug; 53(4):690-700. PubMed ID: 22683604
[TBL] [Abstract][Full Text] [Related]
7. Caffeic acid prevents acetaminophen-induced liver injury by activating the Keap1-Nrf2 antioxidative defense system.
Pang C; Zheng Z; Shi L; Sheng Y; Wei H; Wang Z; Ji L
Free Radic Biol Med; 2016 Feb; 91():236-46. PubMed ID: 26721592
[TBL] [Abstract][Full Text] [Related]
8. Arsenic induces NAD(P)H-quinone oxidoreductase I by disrupting the Nrf2 x Keap1 x Cul3 complex and recruiting Nrf2 x Maf to the antioxidant response element enhancer.
He X; Chen MG; Lin GX; Ma Q
J Biol Chem; 2006 Aug; 281(33):23620-31. PubMed ID: 16785233
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen sulfide attenuates calcification of vascular smooth muscle cells via KEAP1/NRF2/NQO1 activation.
Aghagolzadeh P; Radpour R; Bachtler M; van Goor H; Smith ER; Lister A; Odermatt A; Feelisch M; Pasch A
Atherosclerosis; 2017 Oct; 265():78-86. PubMed ID: 28865326
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Nrf2/Keap1 system by Wasabi 6-methylthiohexyl isothiocyanate in ARE-mediated NQO1 expression.
Korenori Y; Tanigawa S; Kumamoto T; Qin S; Daikoku Y; Miyamori K; Nagai M; Hou DX
Mol Nutr Food Res; 2013 May; 57(5):854-64. PubMed ID: 23390006
[TBL] [Abstract][Full Text] [Related]
11. Induction of NAD(P)H:quinone oxidoreductase 1 expression by cysteine via Nrf2 activation in human intestinal epithelial LS180 cells.
Satsu H; Chidachi E; Hiura Y; Ogiwara H; Gondo Y; Shimizu M
Amino Acids; 2012 Oct; 43(4):1547-555. PubMed ID: 22302369
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel small-molecule Keap1-Nrf2 PPI inhibitor with cytoprotective effects on LPS-induced cardiomyopathy.
Jiang CS; Zhuang CL; Zhu K; Zhang J; Muehlmann LA; Figueiró Longo JP; Azevedo RB; Zhang W; Meng N; Zhang H
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):833-841. PubMed ID: 29693453
[TBL] [Abstract][Full Text] [Related]
13. Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson's disease animal model.
Kim S; Indu Viswanath AN; Park JH; Lee HE; Park AY; Choi JW; Kim HJ; Londhe AM; Jang BK; Lee J; Hwang H; Lim SM; Pae AN; Park KD
Neuropharmacology; 2020 May; 167():107989. PubMed ID: 32032607
[TBL] [Abstract][Full Text] [Related]
14. Structure-based molecular hybridization design of Keap1-Nrf2 inhibitors as novel protective agents of acute lung injury.
Zhang L; Xu L; Chen H; Zhang W; Xing C; Qu Z; Yu J; Zhuang C
Eur J Med Chem; 2021 Oct; 222():113599. PubMed ID: 34119834
[TBL] [Abstract][Full Text] [Related]
15. Alleviation of cadmium-induced oxidative stress by trehalose via inhibiting the Nrf2-Keap1 signaling pathway in primary rat proximal tubular cells.
Wang XY; Wang ZY; Zhu YS; Zhu SM; Fan RF; Wang L
J Biochem Mol Toxicol; 2018 Jan; 32(1):. PubMed ID: 29140578
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel indole derivatives acting as inhibitors of the Keap1-Nrf2 interaction.
Cosimelli B; Greco G; Laneri S; Novellino E; Sacchi A; Amendola G; Cosconati S; Bortolozzi R; Viola G
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1152-1157. PubMed ID: 31179771
[TBL] [Abstract][Full Text] [Related]
17. The natural compound 2,3,5,4'-tetrahydroxystilbene-2-O-β-d glucoside protects against adriamycin-induced nephropathy through activating the Nrf2-Keap1 antioxidant pathway.
Lin EY; Bayarsengee U; Wang CC; Chiang YH; Cheng CW
Environ Toxicol; 2018 Jan; 33(1):72-82. PubMed ID: 29064158
[TBL] [Abstract][Full Text] [Related]
18. Zearalenone induced oxidative stress in the jejunum in postweaning gilts through modulation of the Keap1-Nrf2 signaling pathway and relevant genes1.
Cheng Q; Jiang S; Huang L; Ge J; Wang Y; Yang W
J Anim Sci; 2019 Apr; 97(4):1722-1733. PubMed ID: 30753491
[TBL] [Abstract][Full Text] [Related]
19. Radiomodulatory effect of a non-electrophilic NQO1 inducer identified in a screen of new 6, 8-diiodoquinazolin-4(3H)-ones carrying a sulfonamide moiety.
Soliman AM; Karam HM; Mekkawy MH; Higgins M; Dinkova-Kostova AT; Ghorab MM
Eur J Med Chem; 2020 Aug; 200():112467. PubMed ID: 32502866
[TBL] [Abstract][Full Text] [Related]
20. Implementation of a high-throughput screen for identifying small molecules to activate the Keap1-Nrf2-ARE pathway.
Wu KC; McDonald PR; Liu JJ; Chaguturu R; Klaassen CD
PLoS One; 2012; 7(10):e44686. PubMed ID: 23056183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
